Neglected zoonoses and antimicrobial resistance : impact on one health and sustainable development goals /

Neglected Zoonoses and Antimicrobial Resistance: Impact on One Health and Sustainable Development Goals provides a thorough examination of how neglected zoonoses and antimicrobial resistance together hinder the achievement of sustainable development goals declared by the United Nations in the pursui...

Full description

Bibliographic Details
Corporate Author:	ScienceDirect (Online service)
Other Authors:	Samanta, Indranil (Editor), Bandyopadhyay, Samiran (Editor), Sparagano, Olivier A. E. (Editor)
Format:	eBook
Language:	English
Published:	London ; San Diego, CA: Academic Press, an imprint of Elsevier, [2025]
Subjects:	Zoonoses. Zoonoses Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

Front Cover
NEGLECTED ZOONOSES AND ANTIMICROBIAL RESISTANCE
NEGLECTED ZOONOSES AND ANTIMICROBIAL RESISTANCE: IMPACT ON ONE HEALTH AND SUSTAINABLE DEVELOPMENT GOALS
Copyright
Dedication
Contents
Contributors
About the editors
Preface
1
Sustainable Development Goal
1. Sustainable Development Goals
2. Origin of SDG: Transition from MDG
References
2
Neglected zoonotic diseases
1. Introduction
1.1 Understanding neglected zoonotic diseases
1.2 Impact and consequences
2. Conclusion
References
3
Neglected cystic and alveolar echinococcosis
1. Public health relevance, risk factors, taxonomy, and genetic variation
1.1 Public health relevance
1.2 Risk factors
1.3 Taxonomy and genetic variation
2. Biology and ecology of E. multilocularis and E. granulosus s.l.
2.1 Life cycles of Echinococcus granulosus sensu lato complex
2.2 Life cycle of Echinococcus multilocularis
2.3 Infectivity, pathogenicity, and parasite-host interactions
3. Epidemiology of cystic and alveolar echinococcosis
3.1 Global distribution of cystic echinococcosis
3.2 Global distribution of alveolar echinococcosis
4. Surveillance and control of cystic and alveolar echinococcosis
4.1 Surveillance and control of cystic echinococcosis
4.1.1 Targeted control programme for CE
4.1.2 Focus on the control options for E. granulosus s.l.
4.1.3 Focus on the surveillance options for E. granulosus s.l.
4.1.4 Assumptions and ultimate goals for a successful CE control programme
4.2 Surveillance and control options for alveolar echinococcosis
4.2.1 Surveillance of E. multilocularis in foxes
4.2.2 Control of E. multilocularis in foxes
5. Diagnosis and clinical management of cystic and alveolar echinococcosis?
5.1 Clinical features of human cystic and alveolar echinococcosis.
5.2 Diagnosis of cystic and alveolar echinococcosis
5.2.1 Laboratory diagnosis
5.3 Clinical management of cystic and alveolar echinococcosis
References
4
Cysticercosis: Matter of concern
1. Mode of transmission
2. Disease process
3. Changeover of the traditional clinical symptoms into the current one/epidemiology
4. Modern diagnostic techniques
5. Treatment protocol
6. Antiparasitic resistance
7. Prevention and control strategy
8. Vaccines used recently or under development
9. Conclusion
References
5
Zoonotic sleeping sickness (Trypanosoma brucei)
1. Introduction
2. Morphology and life cycle of Trypanosoma brucei
3. Circadian disruption by sleeping sickness infection
4. Infection and disease course
5. Epidemiology, transmission, and risk factors
6. Diagnosis
7. Treatment and management
8. In gambiense-HAT
9. In rhodesiense-HAT
10. Elimination strategies
11. Vector control strategy
12. Conclusion
References
6
Leishmaniasis
1. Introduction
2. Etiology
3. Distribution
4. Host species and reservoirs
5. Transmission and life cycle
6. Pathogenesis
7. Clinical features
8. Diagnosis
9. Treatment
9.1 Pentavalent antimonials
9.2 Amphotericin B
9.3 Pentamidine
9.4 Paromomycin
9.5 Miltefosine
9.6 Sitamaquine
9.7 Immunotherapy
10. Prevention and control
10.1 Personal protection
10.2 Chemical control
10.3 Environmental modification
10.4 Reservoir control
10.5 Health education
10.6 Vaccines
References
7
Zoonotic tuberculosis
1. Introduction
2. Mycobacteria
3. The importance of zoonotic tuberculosis
4. Pathogenesis, clinical presentation, and pathology
5. Diagnostic techniques
6. Strategies of TB control and treatment
7. Vaccines
8. Conclusion remarks
References.
8
Anthrax
1. Epidemiological distribution
2. Etiology
3. Hosts
4. Mode of transmission
5. Disease process
6. Changeover of the traditional clinical symptoms into the current one
7. Economic importance
8. Modern diagnostic techniques
9. Treatment protocol
10. Antibacterial resistance
11. Prevention and control strategies
12. Vaccines used recently or under development
13. Conclusion
Acknowledgments
References
Further reading
9
Brucellosis: A neglected zoonosis
1. Introduction
2. Etiology
3. Brucella genome
4. Distribution and population at risk
5. Socioeconomic impact
6. Hosts and mode of transmission
7. Risk factors associated with transmission
8. Diagnosis
9. Control measures
10. Conclusion
References
10
Leptospirosis
1. Introduction
2. Etiology
3. Host range
4. Mode of transmission
5. Disease process
5.1 Leptospiral antigens and their role
5.2 Adhesion to the cells and entry
5.3 Virulence factors and the host's immune system's evasion
5.4 Disease development
6. Changeover of the traditional clinical symptoms into the current one
6.1 In humans
6.2 In animals
6.2.1 Cattle
6.2.2 Buffalo
6.2.3 Sheep
6.2.4 Goat
6.2.5 Swine
6.2.6 Horses and other pack animals
6.2.7 Dog
6.2.8 Cat
7. Economic importance
8. Treatment protocol
8.1 In humans
8.2 In animals
9. Antibacterial resistance
10. Prevention and control strategy
11. Vaccines used recently or under development
11.1 Bacterins
11.2 Attenuated vaccines
11.3 LPS-depleted vaccines
11.4 Recombinant protein vaccines
11.5 Recombinant subunit vaccine
11.6 DNA vaccines
12. Conclusion
References
11
Relapsing fever borreliosis
1. Introduction
2. History
3. Distribution
3.1 Africa
3.2 Asia and Eurasia.
3.3 Europe
3.4 The Americas
4. Epidemiology
4.1 Louse-borne relapsing fever
4.2 Tick-borne relapsing fever
5. Etiology
6. Hosts
6.1 Rodents
6.2 Avians
6.3 Bats
6.4 Livestock and other animals
7. Mode of transmission
8. Disease process
8.1 Vector-Borrelia interactions
8.2 Host interactions
9. Changeover of the clinical symptoms
10. Economic importance
11. Classical and modern diagnostic techniques
11.1 Microscopical examination
11.2 Serological methods
11.3 In vitro cultivation
11.4 Polymerase chain reaction
11.5 LTT, MELISA, and ELISpot tests
11.6 Luminex-based, Immuno-PCR techniques
12. Treatment protocol and antibacterial resistance
12.1 Louse-borne relapsing fever
12.2 Tick-borne relapsing fever
12.3 Additional considerations
13. Prevention and control strategies
13.1 Louse-borne RF
13.2 Tick-borne RF
14. Vaccines
References
12
Rickettsioses
1. Introduction
2. Distribution and epidemiology
3. Etiology
4. Hosts
5. Mode of transmission
6. Pathogenesis
7. Clinical manifestations
7.1 Rickettsioses syndrome with a low probability of inoculation eschar
7.2 Rickettsioses syndrome with a probability of inoculation eschar
8. Economic importance
9. Diagnosis
10. Treatment
10.1 Antibacterial resistance
11. Prevention and control
11.1 Vaccines used recently or under development
References
13
Rabies
1. Introduction
2. Etiology
3. Host
4. Modes of transmission
5. Disease process
6. Incubation period
7. Epidemiology
8. Clinical manifestation of rabies
9. Changeover of traditional clinical symptoms into current ones
10. Economic importance of rabies
11. Diagnosis
12. Prevention and control strategy
12.1 Prevention and control in animals.
12.2 Prevention and control in humans
13. Treatment protocol
14. Vaccines used recently or under development
14.1 Vaccines for use in domestic animals
14.2 Vaccines for use in wild animals
14.3 Vaccines for use in humans
15. How rabies control is related to sustainable development goals?
16. Some neglected but significant issues in rabies control
16.1 Rabies in wildlife and its possible role in spillover to domestic animals and humans
16.2 Role of waste management on stray dog population management and rabies control
16.3 Influence of socioeconomic factors in the control of rabies
16.4 Role of epidemiological modeling techniques in rabies prevention and control
16.5 Lack of inclusion of PrEP in human immunization programs
17. Conclusions
Acknowledgments
References
14
Zoonotic antimicrobial resistance: Impact on human and animal health
1. Definition
2. Characteristics
3. Correlation with neglected zoonotic diseases
4. Impact on animal health
5. Impact on human health
References
Further reading
15
Dual obstacles to sustainable development goals
1. How NZDs affect SDGs?
2. What an antimicrobial resistance affects SDG?
References
16
Mitigation strategy for neglected zoonotic diseases and antimicrobial resistance
1. Introduction
2. Mitigation strategies
2.1 Food-borne-related NZDs
2.2 Human and anthropogenic factors
2.3 Environmental factors
3. Antimicrobial resistance
4. Conclusion
References
Index
Back Cover.